Disease #05520 (migraine (migraine (MGR)))

Official abbreviation	migraine
Name	migraine (MGR)
OMIM ID	-
Inheritance	-
Individuals reported having this disease	426
Phenotype entries for this disease	417
Associated with 0 genes	-
Associated tissues	-
Disease features	-
Remarks	-
Date created	2018-11-18 16:51:01 +01:00 (CET)
Date last edited	2020-09-02 08:49:23 +02:00 (CEST)

Individuals

Legend

Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.

ID_report: ID of the individual that can be publically shared, e.g. as listed in a publication

Reference: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"

Remarks: remarks about the individual

Gender: gender individual
All options:

? = unknown
- = not applicable
F = female
M = male
rF = raised as female
rM = raised as male

Consanguinity: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:

no = non-consanguineous parents
yes = consanguineous parents
likely = consanguinity likely
? = unknown
- = not applicable

Country: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:

? (unknown)
- (not applicable)
Afghanistan
(Afghanistan)
Albania
(Albania)
Algeria
(Algeria)
American Samoa
(American Samoa)
Andorra
(Andorra)
Angola
(Angola)
Anguilla
(Anguilla)
Antarctica
(Antarctica)
Antigua and Barbuda
(Antigua and Barbuda)
Argentina
(Argentina)
Armenia
(Armenia)
Aruba
(Aruba)
Australia
(Australia)
Austria
(Austria)
Azerbaijan
(Azerbaijan)
Bahamas
(Bahamas)
Bahrain
(Bahrain)
Bangladesh
(Bangladesh)
Barbados
(Barbados)
Belarus
(Belarus)
Belgium
(Belgium)
Belize
(Belize)
Benin
(Benin)
Bermuda
(Bermuda)
Bhutan
(Bhutan)
Bolivia
(Bolivia)
Bosnia and Herzegovina
(Bosnia and Herzegovina)
Botswana
(Botswana)
Bouvet Island
(Bouvet Island)
Brazil
(Brazil)
British Indian Ocean Territory
(British Indian Ocean Territory)
Brunei Darussalam
(Brunei Darussalam)
Bulgaria
(Bulgaria)
Burkina Faso
(Burkina Faso)
Burundi
(Burundi)
Cambodia
(Cambodia)
Cameroon
(Cameroon)
Canada
(Canada)
Cape Verde
(Cape Verde)
Cayman Islands
(Cayman Islands)
Central African Republic
(Central African Republic)
Central Europe
Chad
(Chad)
Chile
(Chile)
China
(China)
Christmas Island
(Christmas Island)
Cocos (Keeling Islands)
(Cocos (Keeling Islands))
Colombia
(Colombia)
Comoros
(Comoros)
Congo
(Congo)
Cook Islands
(Cook Islands)
Costa Rica
(Costa Rica)
Cote D'Ivoire (Ivory Coast)
(Cote D'Ivoire (Ivory Coast))
Croatia (Hrvatska)
(Croatia (Hrvatska))
Cuba
(Cuba)
Cyprus
(Cyprus)
Czech Republic
(Czech Republic)
Denmark
(Denmark)
Djibouti
(Djibouti)
Dominica
(Dominica)
Dominican Republic
(Dominican Republic)
East Timor
(East Timor)
Ecuador
(Ecuador)
Egypt
(Egypt)
El Salvador
(El Salvador)
England
(England)
Equatorial Guinea
(Equatorial Guinea)
Eritrea
(Eritrea)
Estonia
(Estonia)
Ethiopia
(Ethiopia)
Falkland Islands (Malvinas)
(Falkland Islands (Malvinas))
Faroe Islands
(Faroe Islands)
Fiji
(Fiji)
Finland
(Finland)
France
(France)
Gabon
(Gabon)
Gambia
(Gambia)
Georgia
(Georgia)
Germany
(Germany)
Ghana
(Ghana)
Gibraltar
(Gibraltar)
Greece
(Greece)
Greenland
(Greenland)
Grenada
(Grenada)
Guadeloupe
(Guadeloupe)
Guam
(Guam)
Guatemala
(Guatemala)
Guiana, French
(Guiana, French)
Guinea
(Guinea)
Guinea-Bissau
(Guinea-Bissau)
Guyana
(Guyana)
Haiti
(Haiti)
Heard and McDonald Islands
(Heard and McDonald Islands)
Honduras
(Honduras)
Hong Kong
(Hong Kong)
Hungary
(Hungary)
Iceland
(Iceland)
India
(India)
Indonesia
(Indonesia)
Iran
(Iran)
Iraq
(Iraq)
Ireland
(Ireland)
Israel
(Israel)
Italy
(Italy)
Jamaica
(Jamaica)
Japan
(Japan)
Jordan
(Jordan)
Kazakhstan
(Kazakhstan)
Kenya
(Kenya)
Kiribati
(Kiribati)
Korea
(Korea)
Korea, North (People's Republic)
(Korea, North (People's Republic))
Korea, South (Republic)
(Korea, South (Republic))
Kosovo
(Kosovo)
Kuwait
(Kuwait)
Kyrgyzstan (Kyrgyz Republic)
(Kyrgyzstan (Kyrgyz Republic))
Laos
(Laos)
Latvia
(Latvia)
Lebanon
(Lebanon)
Lesotho
(Lesotho)
Liberia
(Liberia)
Libya
(Libya)
Liechtenstein
(Liechtenstein)
Lithuania
(Lithuania)
Luxembourg
(Luxembourg)
Macau
(Macau)
Macedonia
(Macedonia)
Madagascar
(Madagascar)
Malawi
(Malawi)
Malaysia
(Malaysia)
Maldives
(Maldives)
Mali
(Mali)
Mallorca
(Mallorca)
Malta
(Malta)
Marshall Islands
(Marshall Islands)
Martinique
(Martinique)
Mauritania
(Mauritania)
Mauritius
(Mauritius)
Mayotte
(Mayotte)
Mexico
(Mexico)
Micronesia
(Micronesia)
Moldova
(Moldova)
Monaco
(Monaco)
Mongolia
(Mongolia)
Montserrat
(Montserrat)
Morocco
(Morocco)
Mozambique
(Mozambique)
Myanmar
(Myanmar)
Namibia
(Namibia)
Nauru
(Nauru)
Nepal
(Nepal)
Netherlands
(Netherlands)
Netherlands Antilles
(Netherlands Antilles)
Neutral Zone (Saudia Arabia/Iraq)
(Neutral Zone (Saudia Arabia/Iraq))
New Caledonia
(New Caledonia)
New Zealand
(New Zealand)
Nicaragua
(Nicaragua)
Niger
(Niger)
Nigeria
(Nigeria)
Niue
(Niue)
Norfolk Island
(Norfolk Island)
Northern Ireland
(Northern Ireland)
Northern Mariana Islands
(Northern Mariana Islands)
Norway
(Norway)
Oman
(Oman)
Pakistan
(Pakistan)
Palau
(Palau)
Palestine
(Palestine)
Panama
(Panama)
Papua New Guinea
(Papua New Guinea)
Paraguay
(Paraguay)
Peru
(Peru)
Philippines
(Philippines)
Pitcairn
(Pitcairn)
Poland
(Poland)
Polynesia, French
(Polynesia, French)
Portugal
(Portugal)
Puerto Rico
(Puerto Rico)
Qatar
(Qatar)
Reunion
(Reunion)
Romania
(Romania)
Russia
(Russia)
Russian Federation
(Russian Federation)
Rwanda
(Rwanda)
S. Georgia and S. Sandwich Isls.
(S. Georgia and S. Sandwich Isls.)
Saint Kitts and Nevis
(Saint Kitts and Nevis)
Saint Lucia
(Saint Lucia)
Saint Vincent and The Grenadines
(Saint Vincent and The Grenadines)
Samoa
(Samoa)
San Marino
(San Marino)
Sao Tome and Principe
(Sao Tome and Principe)
Saudi Arabia
(Saudi Arabia)
Scotland
(Scotland)
Senegal
(Senegal)
Serbia
(Serbia)
Seychelles
(Seychelles)
Sierra Leone
(Sierra Leone)
Singapore
(Singapore)
Slovakia (Slovak Republic)
(Slovakia (Slovak Republic))
Slovenia
(Slovenia)
Solomon Islands
(Solomon Islands)
Somalia
(Somalia)
South Africa
(South Africa)
Southern Territories, French
(Southern Territories, French)
Soviet Union (former)
(Soviet Union (former))
Spain
(Spain)
Sri Lanka
(Sri Lanka)
St. Helena, Ascension and Tristan da
Cunha
(St. Helena, Ascension and Tristan da
Cunha)
St. Pierre and Miquelon
(St. Pierre and Miquelon)
Sudan
(Sudan)
Sudan, South
(Sudan, South)
Suriname
(Suriname)
Svalbard and Jan Mayen Islands
(Svalbard and Jan Mayen Islands)
Swaziland
(Swaziland)
Sweden
(Sweden)
Switzerland
(Switzerland)
Syria
(Syria)
Taiwan
(Taiwan)
Tajikistan
(Tajikistan)
Tanzania
(Tanzania)
Thailand
(Thailand)
Togo
(Togo)
Tokelau
(Tokelau)
Tonga
(Tonga)
Trinidad and Tobago
(Trinidad and Tobago)
Tunisia
(Tunisia)
Turkey
(Turkey)
Turkmenistan
(Turkmenistan)
Turks and Caicos Islands
(Turks and Caicos Islands)
Tuvalu
(Tuvalu)
Uganda
(Uganda)
Ukraine
(Ukraine)
United Arab Emirates
(United Arab Emirates)
United Kingdom (Great Britain)
(United Kingdom (Great Britain))
United States
(United States)
Uruguay
(Uruguay)
US Minor Outlying Islands
(US Minor Outlying Islands)
Uzbekistan
(Uzbekistan)
Vanuatu
(Vanuatu)
Vatican City State (Holy See)
(Vatican City State (Holy See))
Venezuela
(Venezuela)
Viet Nam
(Viet Nam)
Virgin Islands (British)
(Virgin Islands (British))
Virgin Islands (US)
(Virgin Islands (US))
Wales
(Wales)
Wallis and Futuna Islands
(Wallis and Futuna Islands)
Western Sahara
(Western Sahara)
Yemen
(Yemen)
Yugoslavia
(Yugoslavia)
Zaire
(Zaire)
Zambia
(Zambia)
Zimbabwe
(Zimbabwe)

Population: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.

Age at death: age at which the individual deceased (when applicable):

35y = 35 years
>43y = still alive at 43y
04y08m = 4 years and 8 months
00y00m01d12h = 1 day and 12 hours
18y? = around 18 years
30y-40y = between 30 and 40 years
>54y = older than 54
? = unknown

VIP: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.

Data_av: are additional data available upon request: e.g. pedigree (yes/no/?)

Treatment: treatment of patient

Variants in genes: The individual has variants for this gene.

Panel size: Number of individuals this entry represents; e.g. 1 for an individual, 5 for a family with 5 affected members.

How to query this table

All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.

Operator	Column type	Example	Matches
	Text	Arg	all entries containing 'Arg'
space	Text	Arg Ser	all entries containing 'Arg' and 'Ser'
\|	Text	Arg\|Ser	all entries containing 'Arg' or 'Ser'
!	Text	!fs	all entries not containing 'fs'
^	Text	^p.(Arg	all entries beginning with 'p.(Arg'
$	Text	Ser)$	all entries ending with 'Ser)'
=""	Text	=""	all entries with this field empty
=""	Text	="p.0"	all entries exactly matching 'p.0'
!=""	Text	!=""	all entries with this field not empty
!=""	Text	!="p.0"	all entries not exactly matching 'p.0?'
combination	Text	*\|Ter !fs	all entries containing '*' or 'Ter' but not containing 'fs'
	Date	2020	all entries matching the year 2020
\|	Date	2020-03\|2020-04	all entries matching March or April, 2020
!	Date	!2020-03	all entries not matching March, 2020
<	Date	<2020	all entries before the year 2020
<=	Date	<=2020-06	all entries in or before June, 2020
>	Date	>2020-06	all entries after June, 2020
>=	Date	>=2020-06-15	all entries on or after June 15th, 2020
combination	Date	2019\|2020 <2020-03	all entries in 2019 or 2020, and before March, 2020
	Numeric	23	all entries exactly matching 23
\|	Numeric	23\|24	all entries exactly matching 23 or 24
!	Numeric	!23	all entries not exactly matching 23
<	Numeric	<23	all entries lower than 23
<=	Numeric	<=23	all entries lower than, or equal to, 23
>	Numeric	>23	all entries higher than 23
>=	Numeric	>=23	all entries higher than, or equal to, 23
combination	Numeric	>=20 <30 !23	all entries with values from 20 to 29, but not equal to 23

Some more advanced examples:

Example	Matches
Asian	all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian	all entries containing 'Asian' but not containing 'Caucasian'
Asian\|African !Caucasian	all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"	all entries containing 'South Asian', but not containing 'South East Asian'

To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.

426 entries on 5 pages. Showing entries 1 - 100.

	Legend	How to query	« First	‹ Prev		1	2	3	4	5		Next ›	Last »

Individual ID	ID_report	Reference	Remarks	Gender	Consanguinity	Country	Population	Age at death	VIP	Data_av	Treatment	Disease	Phenotype details	Genes screened	Variants in genes	Variants	Panel size	Owner
00207087	-	PubMed: Tonelli 2007	Triggering factors of hemiplegic migraine: physical and emotional stress	F	-	Italy	-	-	-	-	Triptans	migraine	1st hemiplegic migraine attack 30y, duration 1st aura 3-5hmin, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 3-4h, 1st HMA moderate	ATP1A2	ATP1A2	1	1	Paola Carrera
00207088	-	PubMed: Tonelli 2007	Triggering factors of hemiplegic migraine: physical and emotional stress	F	-	Italy	-	-	-	-	Triptans	migraine	1st hemiplegic migraine attack 40y, duration 1st aura 1-3dmin, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 5-6h, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207089	-	PubMed: Tonelli 2007	Triggering factors of hemiplegic migraine: physical and emotional stress	M	-	Italy	-	-	-	-	Triptans	migraine	1st hemiplegic migraine attack 14y, duration 1st aura 1-3dmin, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 3-4h, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207090	-	PubMed: Riant 2005	Genotyping of relatives identified 6 mutation carriers, among whom 5 were clinically affected. In addition 1 phenocopy was present.	F	-	France	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207091	-	PubMed: Vanmolkot 2007	-	-	-	-	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	2	3	Paola Carrera
00207092	-	PubMed: Spadaro 2004	-	F	-	Italy	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 52y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; PermCer status nystagmus, dysarthria, ataxia, MRI(72 years) marked cerebellar and vermis atrophy	ATP1A2	ATP1A2	1	1	Paola Carrera
00207093	-	PubMed: Spadaro 2004	-	F	-	Italy	-	-	-	-	Phenobarbital 100 mg/day	migraine	1st hemiplegic migraine attack 25y, 1st HMA hemiparesis left, 1st HMA hemiparesis right, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; 1st severe attack 25y, 1st severe attack signs Somnolence/fever/epileptic Seizures; PermCer status nystagmus, dysarthria, ataxia, MRI diffuse edema;cerebellar signs	ATP1A2	ATP1A2	1	1	Paola Carrera
00207095	-	PubMed: Spadaro 2004	-	M	-	Italy	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 29y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; 1st severe attack signs mild coma/fever	ATP1A2	ATP1A2	1	1	Paola Carrera
00207096	-	PubMed: Spadaro 2004	-	M	-	Italy	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 21y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; 1st severe attack signs mild coma/fever	ATP1A2	ATP1A2	1	1	Paola Carrera
00207097	-	PubMed: Spadaro 2004	-	F	-	Italy	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 34y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207098	-	PubMed: Spadaro 2004	-	F	-	Italy	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 12y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 12y, 1st severe attack hemiparesis not left, 1st severe attack hemiparesis right, 1st severe attack signs confusion/mild coma/fever/epileptic Seizures	ATP1A2	ATP1A2	1	1	Paola Carrera
00207099	-	PubMed: Spadaro 2004	-	M	-	Italy	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 6y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack signs Somnolence/confusion/mild coma/fever	ATP1A2	ATP1A2	1	1	Paola Carrera
00207100	-	PubMed: Spadaro 2004	-	F	-	Italy	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 26y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207101	-	PubMed: Kaunisto 2004	-	F	-	Finland	-	-	-	-	no treatment known	migraine	1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA mild	ATP1A2	ATP1A2	1	1	Paola Carrera
00207103	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 13y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207104	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 5y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207105	-	PubMed: Castro 2007	-	M	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 7y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207106	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 14y, duration 1st aura 600min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207107	-	PubMed: Castro 2007	-	M	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 12y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207108	-	PubMed: Castro 2007	-	M	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 8y, duration 1st aura 60min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207109	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	unaffected	ATP1A2	ATP1A2	1	1	Paola Carrera
00207110	-	PubMed: Castro 2007	-	M	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 10y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207111	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 14y, duration 1st aura 20min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207112	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 6y, duration 1st aura 10min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207113	-	PubMed: Riant 2005	Genotyping of relatives identified 2 mutation carriers, clinically affected.	M	-	Italy	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207114	-	PubMed: Riant 2005	Genotyping of relatives identified 5 mutation carriers, among whom 4 were clinically affected, and 1 with clinical information unavailable.	M	-	France	-	-	-	-	-	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207115	-	PubMed: Swoboda 2004	-	F	-	Greece	-	-	-	-	Flunarizine	migraine	1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; PermCer status, no nystagmus, dysarthria, no ataxia	ATP1A2	ATP1A2	1	1	Paola Carrera
00207116	-	PubMed: Swoboda 2004	-	M	-	Greece	-	-	-	-	Flunarizine	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207117	-	PubMed: Swoboda 2004	-	M	-	Greece	-	-	-	-	Flunarizine	migraine	1st hemiplegic migraine attack 2y, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207118	-	PubMed: Swoboda 2004	-	M	-	Greece	-	-	-	-	Flunarizine	migraine	1st hemiplegic migraine attack 1y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207119	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 11y, duration 1st aura 300min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207120	-	PubMed: Lebas 2008	-	F	-	France	-	-	-	-	paracetamol	migraine	1st hemiplegic migraine attack 13y, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence, 1st HMA duration headache 2d	ATP1A2	ATP1A2	1	1	Paola Carrera
00207121	-	PubMed: Lebas 2008	-	M	-	France	-	-	-	-	-	migraine	1st hemiplegic migraine attack 13y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 48h; 1st severe attack 13y, duration aura 4, 1st severe attack signs confusion/fever	ATP1A2	ATP1A2	1	1	Paola Carrera
00207122	-	PubMed: Lebas 2008	-	F	-	France	-	-	-	-	paracetamol	migraine	1st hemiplegic migraine attack 7y, duration 1st aura 60min, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 4d	ATP1A2	ATP1A2	1	1	Paola Carrera
00207123	-	PubMed: Lebas 2008	-	F	-	France	-	-	-	-	sodium valproate	migraine	1st hemiplegic migraine attack 4y, duration 1st aura 15min, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 5y, 1st severe attack signs confusion/fever/epileptic seizures	ATP1A2	ATP1A2	1	1	Paola Carrera
00207124	-	PubMed: Vanmolkot 2006	Haplotype analysis showed that the mutation occurred de novo.	F	-	Netherlands	-	-	-	-	valproic acid, improved	migraine	1st hemiplegic migraine attack 4y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207125	-	PubMed: Vanmolkot 2006	-	F	-	Netherlands	-	-	-	-	-	migraine	1st hemiplegic migraine attack 17y, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207126	-	PubMed: Riant 2005	Genotyping of relatives identified 2 mutation carriers, clinically affected.	M	-	France	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207127	-	PubMed: Riant 2005	Genotyping of relatives identified 3 mutation carriers, clinically affected.	M	-	Portugal	-	-	-	-	-	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207129	-	PubMed: Jen 2007	The young girl developed left-sided numbness and paralysis after 2 days of a severe right-sided headache.The hemiparesis was dense for 5 days and then gradually resolved over the next few days.	F	-	-	white	-	-	-	-	migraine	1st hemiplegic migraine attack 9y, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 2d, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207130	-	PubMed: Riant 2005	Genotyping of relatives identified 1 mutation carrier, clinically affected.	F	-	Switzerland	-	-	-	-	-	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207131	-	PubMed: Vanmolkot 2006	p.Gly615Arg is located in the highly conserved "TGD" motif of the ATP-binding domain.	F	-	Netherlands	-	-	-	-	-	migraine	episodes sometimes provoked by phisical exercise or a fall on the head; 1st hemiplegic migraine attack 3y, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207132	-	PubMed: Vanmolkot 2006	In the proband , this mutation is associated with a drastic clinical phenotype consisting of both episodic and permanent severe neurological features starting at a young age; The episodic symptoms were precipitated by mild head trauma and included hemiplegia,epileptic seizures and cortical blindness; Her father (II.6) reported that he, his brother (II.5) and his sister (II.4) were diagnosed with childhood epilepsy. Retrospectively, II.4, II.5 and II.6 most likely had hemiplegic migraine with a few episodes of confusional migraine; The p.Gly615Arg is located in the highly conserved "TGD" motif of the ATP-binding domain.	F	-	Netherlands	-	-	-	-	Acetazolamide, resolution symptoms	migraine	1st hemiplegic migraine attack 4y, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence; 1st severe attack 4y, 1st severe attack signs Somnolence/confusion/fever/epileptic seizures	ATP1A2	ATP1A2	1	1	Paola Carrera
00207133	-	PubMed: Vanmolkot 2006	Family 1 is the first Turkish family reported with FHM; haplotype analysis showed that the mutation occurred "de novo".	F	-	Turkey	-	-	-	-	-	migraine	1st hemiplegic migraine attack 13y, duration 1st aura 30min, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207134	-	PubMed: Vanmolkot 2006	Twin brother IV.2. Two affected sisters (IV.3, IV.4) with the p. Val628Met mutation; Family 1 is the first Turkish family reported with FHM.	M	-	Turkey	-	-	-	-	-	migraine	1st hemiplegic migraine attack 18y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207135	-	PubMed: Vanmolkot 2006	Twin brother IV.1. Two affected sisters (IV.3, IV.4) with the p. Val628Met mutation; Family 1 is the first Turkish family reported with FHM.	M	-	Turkey	-	-	-	-	-	migraine	1st hemiplegic migraine attack 13y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207136	-	PubMed: Vanmolkot 2006	Family 1 is the first Turkish family reported with FHM	F	-	Turkey	-	-	-	-	-	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207137	-	PubMed: Vanmolkot 2006	Family 1 is the first Turkish family reported with FHM.	F	-	Turkey	-	-	-	-	-	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207139	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 14y, duration 1st aura 105min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207140	-	PubMed: Vanmolkot 2003	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207142	-	PubMed: Vanmolkot 2003	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207143	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 14y, duration 1st aura 60min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207144	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 10y, duration 1st aura 60min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207146	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 18y, duration 1st aura 120min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207147	-	PubMed: Vanmolkot 2003	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207148	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207149	-	PubMed: Vanmolkot 2003	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 19y, duration 1st aura 120min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207150	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207151	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 10y, duration 1st aura 75min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence, 1st HMA duration headache 720min	ATP1A2	ATP1A2	1	1	Paola Carrera
00207152	-	PubMed: Vanmolkot 2003	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207153	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 4y, 1st severe attack signs confusion	ATP1A2	ATP1A2	1	1	Paola Carrera
00207155	-	PubMed: Vanmolkot 2003, PubMed: Terwindt 1997	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207157	-	PubMed: Pierelli 2006	-	F	-	Italy	-	-	-	-	-	migraine	cold weather and stress were potent attack triggers; 1st hemiplegic migraine attack 6y, duration 1st aura 60min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 180min	ATP1A2	ATP1A2	1	1	Paola Carrera
00207158	-	PubMed: Pierelli 2006	The patient identified several triggers for his attacks, including physical or emotional stress, alcohol intake, cold, minor head trauma and "roasted coffee" smell.	M	-	Italy	-	-	-	-	-	migraine	1st hemiplegic migraine attack 10y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 1d, 1st HMA moderate; 1st severe attack signs confusion	ATP1A2	ATP1A2	1	1	Paola Carrera
00207159	-	PubMed: Pierelli 2006	His first migraine attack was after a minor head trauma sustained while playing soccer; With the exception of the visual disturbances,which disappeared rapidly, full neurological recovery took a few days; He experienced severe attacks with confusion and drowsiness. ; When aged 40, after a cerebral angiography, the procedure was followed by a coma state lasting 3 days.	M	-	Italy	-	-	-	-	-	migraine	1st hemiplegic migraine attack 10y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack signs Somnolence/confusion	ATP1A2	ATP1A2	1	1	Paola Carrera
00207160	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 10y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence, 1st HMA duration headache 420min	ATP1A2	ATP1A2	1	1	Paola Carrera
00207161	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 8y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; PermCer status no nystagmus, no dysarthria, ataxia	ATP1A2	ATP1A2	1	1	Paola Carrera
00207162	-	PubMed: Jurkat-Rott 2004	-	M	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 12y, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207163	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 4y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; PermCer status nystagmus, no dysarthria, no ataxia, Bilateral cerebellar infarcts on MRI	ATP1A2	ATP1A2	1	1	Paola Carrera
00207164	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207165	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 10y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 10y, duration aura 14, 1st severe attack signs complex visual and auditory delusions; PermCer status no nystagmus, no dysarthria, ataxia	ATP1A2	ATP1A2	1	1	Paola Carrera
00207166	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 3y, duration aura 6, 1st severe attack signs confusion/fever; PermCer status no nystagmus, no dysarthria, ataxia	ATP1A2	ATP1A2	1	1	Paola Carrera
00207167	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 15y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA mild	ATP1A2	ATP1A2	1	1	Paola Carrera
00207168	-	PubMed: Castro 2007	-	M	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 10y, duration 1st aura 15min, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA moderate	ATP1A2	ATP1A2	1	1	Paola Carrera
00207169	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 11y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe	ATP1A2	ATP1A2	1	1	Paola Carrera
00207170	-	PubMed: Castro 2007	-	F	-	Portugal	-	-	-	-	-	migraine	1st hemiplegic migraine attack 9y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA mild	ATP1A2	ATP1A2	1	1	Paola Carrera
00207171	-	PubMed: Vanmolkot 2003	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 9y, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207172	-	PubMed: Vanmolkot 2003	-	M	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 11y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207173	-	PubMed: Vanmolkot 2003	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 7y, 1st HMA hemiparesis left, 1st HMA hemiparesis right, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207174	-	PubMed: Vanmolkot 2003	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 14y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207175	-	PubMed: Vanmolkot 2003	-	F	-	Netherlands	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 3y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207176	-	PubMed: Jurkat-Rott 2004	-	M	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack duration 1st aura 210min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 13y, 1st severe attack signs confusion/complex visual and auditory delusions/fever; PermCer status, White matter lesions	ATP1A2	ATP1A2	1	1	Paola Carrera
00207178	-	PubMed: Jurkat-Rott 2004	-	M	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 7y, duration 1st aura 42min, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207179	-	PubMed: De Fusco 2003	-	M	-	Italy	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207180	-	PubMed: De Fusco 2003	-	M	-	Italy	-	-	-	-	Acetazolamide	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207182	-	PubMed: De Fusco 2003	-	M	-	Italy	-	-	-	-	Acetazolamide	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207184	-	PubMed: De Fusco 2003	-	F	-	Italy	-	-	-	-	Acetazolamide	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207185	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 41y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 720min	ATP1A2	ATP1A2	1	1	Paola Carrera
00207186	-	PubMed: Riant 2005	Genotyping of relatives identified 6 mutation carriers, among whom 4 were clinically affected, and 1 with uncertain clinical diagnosis.	F	-	France	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207187	-	PubMed: Riant 2005	Genotyping of relatives identified 14 mutation carriers, among whom 10 were clinically affected and 2 with uncertain clinical diagnosis. In addition 2 phenocopies were present.	M	-	France	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207188	-	PubMed: De Fusco 2003	-	F	-	Italy	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207190	-	PubMed: De Fusco 2003	-	M	-	Italy	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207191	-	PubMed: Jurkat-Rott 2004	Another paper (PMID 15985592: Dreier JP et al.) describes delayed cerebral edema in a patient with the p.Glu902Lys substitution.	M	-	Germany	-	-	-	-	no treatment known	migraine	1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 0y, duration aura 20, 1st severe attack signs confusion/Severe coma/fever	ATP1A2	ATP1A2	1	1	Paola Carrera
00207192	-	PubMed: Riant 2005	Genotyping of relatives identified 7 mutation carriers, among whom 4 were clinically affected.	F	-	France	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207193	-	PubMed: Riant 2005	Genotyping of relatives identified 1 mutation carrier, clinically affected.	M	-	France	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207194	-	PubMed: Riant 2005	Genotyping of relatives identified 1 mutation carrier, clinically affected.	F	-	France	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207195	-	PubMed: Jurkat-Rott 2004	-	M	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 20y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence	ATP1A2	ATP1A2	1	1	Paola Carrera
00207196	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 23y, duration aura 2, 1st severe attack signs confusion; PermCer status nystagmus, no dysarthria, ataxia	ATP1A2	ATP1A2	1	1	Paola Carrera
00207197	-	PubMed: Jurkat-Rott 2004	-	F	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 4y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; PermCer status no nystagmus, no dysarthria, ataxia	ATP1A2	ATP1A2	1	1	Paola Carrera
00207198	-	PubMed: Jurkat-Rott 2004	-	M	-	Germany	-	-	-	-	no treatment known	migraine	1st hemiplegic migraine attack 6y, duration 1st aura 15min, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 180min	ATP1A2	ATP1A2	1	1	Paola Carrera

	Legend	How to query	« First	‹ Prev		1	2	3	4	5		Next ›	Last »

Global Variome shared LOVD

UBASH3B (ubiquitin associated and SH3 domain contai...)